Finorpa key facts
- Finorpa is a growth equity firm based in Lille, France with 14 tracked portfolio companies.
- Notable positions include Hemerion Therapeutics, Lattice Medical, Q de Bouteilles.
About Finorpa
Founded in 1984, Finorpa is a growth equity firm headquartered in Lille, France. The firm provides equity and quasi-equity investments in small and medium enterprises based in France.
Finorpa portfolio at a glance
14 portfolio companies are on record for Finorpa, including Hemerion Therapeutics, Lattice Medical and Q de Bouteilles.
8 of the 14 carry a recorded valuation.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Free account
See more of the book
- ·The top 10 names in the book — of 14 recorded positions
- ·Watchlist + alerts for Finorpa's activity
Portfolio
14 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Hemerion Therapeutics | — | ▮ | ▮ | ▮ |
| Lattice Medical | — | ▮ | ▮ | ▮ |
| Q de Bouteilles | — | ▮ | ▮ | ▮ |
+ 11 more companies · all 14, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Frequently asked about Finorpa
- What companies does Finorpa invest in?
- Finorpa has 14 recorded portfolio companies, including Hemerion Therapeutics, Lattice Medical, Q de Bouteilles.
- What is Finorpa's AUM?
- Finorpa manages approximately $104.4M in assets.